Last reviewed · How we verify
NCT05221996: sIgA
Minimal-Dose Resistance Training for Improving sIgA and Cortisol
NA trial testing Resistance training in Resistance Training in 15 participants. Completed in 24 March 2022.
24 February 2022
Quick facts
| Lead sponsor | Universidad Francisco de Vitoria |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | double |
| Primary purpose | screening |
| Enrollment | 15 |
| Start date | 1 February 2022 |
| Primary completion | 24 February 2022 |
| Estimated completion | 24 March 2022 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Resistance training
Conditions studied
- Resistance Training — all drugs for Resistance Training →
- Immune System — all drugs for Immune System →
Sponsor
Universidad Francisco de Vitoria — full company profile →
Who can join
Adults 18 to 30, any sex, with Resistance Training or Immune System. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Whereas the role of endurance training on immune function has been widely studied, little is known about the role of resistance training (RT). In this cross-over randomized controlled study, it will be analysed the effects of three RT protocols which only differs in volume in improving secretory immunoglobulin A (sIgA) and cortisol in saliva among young, health and sedentary people
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05221996
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Resistance training
Trials testing the same drug.
- NCT07166198 — Mitigating Neural Hypoexcitability and Weakness During Disuse in Women · NA · not yet recruiting
- NCT07411625 — Preoperative Rehabilitation for Patient With an ACL Injury · NA · recruiting
- NCT07484776 — Metabolic Flexibility in Patients With Early Triple-negative Breast Cancer · NA · active not recruiting
- NCT07341698 — Prehabilitation for Patients Diagnosed With Blood Cancer and Treated With Al-logeneic Hematopoietic Stem Cell Transplant · NA · recruiting
- NCT07058818 — Tailored Resistance Training After Adverse Pregnancy Outcomes · NA · completed
Other recruiting trials for Resistance Training
Currently open trials in the same condition.
- NCT06360536 — Remotely Delivered Resistance Training for Cardiometabolic Health Among Black Women · NA · recruiting
- NCT06765486 — Exercise-Induced Hypoalgesia Differences Between Upper and Lower Limbs Resistance Training Interventions · NA · recruiting
- NCT06679491 — Impact of Menstrual Cycle-Based Resistance Training on Neuromuscular Performance in Female Athletes · NA · recruiting
- NCT07347912 — Group-based Resistance Training for Adults With Down Syndrome · NA · active not recruiting
- NCT06536803 — Effects of High Load Strength Training With and Without Tissue Specific Planter Facia Stretching With Planter Fasciitis · NA · recruiting
Other Universidad Francisco de Vitoria trials
Trials by the same sponsor.
- NCT07506343 — SDT-Based Intervention for Exercise Motivation in Female Students · NA · not yet recruiting
- NCT07452237 — Effects of Transcutaneous Neuromodulation and Cervical Exercise in Students With Chronic Nonspecific Cervical Pain · NA · not yet recruiting
- NCT07400900 — Effectiveness of a Standardised Stabilisation Exercise Protocol in Volleyball Players With Non-traumatic Shoulder Instab · NA · not yet recruiting
- NCT07334171 — Inspiratory Muscle Strength and Diaphragm Thickness in People With Shoulder Pain in Tennis Players · active not recruiting
- NCT07328334 — Longitudinal Assessment of Maximal Inspiratory Pressure and Functional Capacity Following Inspiratory Muscle Training in · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05221996 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universidad Francisco de Vitoria
- Last refreshed: 17 May 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05221996.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing